Female Research Metabolic Stack
Combination Kit: Ostarine Tablets, Cardarine Tablets, & Retatrutide Lyophilized Vial
$275.00
Female Research Metabolic Stack
Combination Kit: Ostarine Tablets, Cardarine Tablets, & Retatrutide Lyophilized Vial
The Ultimate Body Recomposition Protocol | Synergistic Fat Oxidation & Lean Tissue Support
The 4Balance Codex: The Metabolic Trifecta. Simultaneous activation of Selective Androgen Receptors (muscle preservation), PPARδ pathways (lipid mobilization), and Triple-Hormone signaling (systemic energy homeostasis).
Product Overview
This exclusive 4Balance Research Stack represents the cutting edge of metabolic and body composition research. It moves beyond traditional protocols by combining selective tissue support with next-generation hormonal modulation.
This kit replaces older compounds with the "Triple G" agonist, Retatrutide, and pairs it with two foundational oral research agents: Ostarine (MK-2866) and Cardarine (GW-501516). We provide the oral agents in precise Tablet format for consistent administration in research settings, alongside the lyophilized peptide.
Mechanism of Action: Synergistic Recomposition Pathways
This stack is designed for research models investigating maximal fat loss while simultaneously preserving lean muscle tissue under conditions of caloric deficit. The synergy occurs across three distinct physiological pathways:
Systemic Metabolic Shift (Retatrutide - 10mg Vial): As a GIP/GLP-1/Glucagon receptor triple agonist, Retatrutide acts as the foundation of the stack. It profoundly suppresses appetite signaling in the brain while concurrently increasing energy expenditure and lipid catabolism via glucagon receptor activation in the liver.
The "Lipid Engine" & Endurance (Cardarine - 10mg Tablets): Cardarine is a PPARδ agonist (not a hormone). It works synergistically with Retatrutide by shifting the body's preferred fuel source from glucose to fatty acids. In research, this enhances endurance and maximizes the burning of stored fat mobilized by the other agents.
Lean Tissue Preservation (Ostarine - 25mg Tablets): In any aggressive fat-loss protocol, muscle catabolism is a primary risk. Ostarine, a Selective Androgen Receptor Modulator (SARM), binds to androgen receptors specifically in muscle and bone tissue. This provides a crucial anabolic signal to preserve lean muscle mass even when calories are significantly restricted by the action of Retatrutide.
Primary Research Applications
In the 4Balance Research Array, this stack is utilized for comprehensive body composition studies:
Aggressive Body Recomposition: Modeling simultaneous fat mass reduction and lean muscle maintenance.
Metabolic Adaptation: Investigating how PPARδ activation (Cardarine) and androgen receptor signaling (Ostarine) mitigate metabolic slowdown during intense GLP-1/Glucagon mediated weight loss (Retatrutide).
Endurance under Deficit: Studying performance output and recovery kinetics during energy-restricted states.
Technical Specifications & Kit Contents
This research stack contains three separate components:
Component 1 (Oral): Ostarine (MK-2866) | 25mg Tablets (100 Count Bottle)
Component 2 (Oral): Cardarine (GW-501516) | 10mg Tablets
Component 3 (Injectable): Retatrutide (Triple Agonist) | 10mg Lyophilized Vial
Purity: All components ≥99% (HPLC Verified)
DISCLAIMER: FOR LABORATORY RESEARCH USE ONLY. This product is a combination of laboratory reagents intended strictly for in-vitro and in-vivo research and development. These products are not drugs, dietary supplements, or treatments for any medical condition. NOT for human consumption, veterinary use, or therapeutic application. Bodily introduction of any kind is strictly prohibited by law. Buyer assumes all responsibility for applicable regulations and appropriate use in a research setting.
